Antibody

Kymab unlocks the power of the mouse

Read more

Europe to tackle antimicrobial resistance

Read more

The perilous state of antibiotic development

Read more

Advancing a modular approach to antibody design

Read more

Antibodies show promise against influenza

Read more

Developing biosimilar monoclonal antibodies will not be easy

Read more

Symphogen sees opportunities in antibody mixtures

Read more

ArGEN-X builds a new antibody business

Read more

EMA guidance on biosimilar monoclonal antibodies

Read more

Affimed brings new antibody to the clinic

Read more